Medicaid Expansion Tied to 1.8‑Point Drop in One‑Year Death Rate for Young Kidney Failure Patients

Medicaid expansion under the Affordable Care Act was associated with a 1.8‑percentage‑point reduction in one‑year mortality among young adults starting dialysis for kidney failure. The study of over 7,000 patients also notes the largest decline in uninsurance among 19‑ to 25‑year‑olds in the same period.

Context Young adults have historically faced the highest uninsured rates in the U.S., losing childhood Medicaid eligibility at age 19 and often working jobs without health benefits. The Affordable Care Act’s Medicaid expansion, enacted in 2010, aimed to close that gap by extending coverage to low‑income adults and allowing dependents to stay on parental plans until age 26. Kidney failure patients in this age group face a mortality risk from heart disease that is 500 times higher than their peers, making timely access to care especially critical.

Key Facts A cohort study published in JAMA Pediatrics examined 7,139 young adults with kidney failure who began dialysis between 2010 and 2019. Researchers compared 19‑ to 23‑year‑olds, whose Medicaid eligibility changed after expansion, with 14‑ to 18‑year‑olds, whose eligibility remained stable. They found that one‑year mortality dropped by a statistically significant 1.8 percentage points after the expansion. Lead author Shailender Swaminathan said, "health insurance is critically important for survival among individuals with a high and constant need for medical care." Separately, uninsurance rates for 19‑ to 25‑year‑olds fell from 31.5 % in 2009 to 13.1 % in 2023, the largest decline of any age group.

What It Means The findings suggest that gaining Medicaid coverage improves pre‑dialysis care, increases dialysis use, and lengthens treatment sessions—factors that can boost survival. For policymakers, the results highlight the potential health gains of maintaining or expanding coverage for young adults with chronic conditions. As debates continue over future Medicaid adjustments, monitoring mortality trends in high‑risk groups will be essential to assess the real‑world impact of coverage changes.

What to watch next Observers should track upcoming federal and state Medicaid proposals, especially any measures that could reduce enrollment, and see whether mortality rates among young dialysis patients rise or fall in response.